Suppr超能文献

尼古丁与酒精代谢的药物遗传学差异:综述及对未来研究的建议

Differences in pharmacogenetics of nicotine and alcohol metabolism: review and recommendations for future research.

作者信息

Wall Tamara L, Schoedel Kerri, Ring Huijun Z, Luczak Susan E, Katsuyoshi Denise M, Tyndale Rachel F

机构信息

Department of Psychiatry, University of California, San Diego, Psychology Service, Veterans Affairs San Diego Healthcare System, San Diego, California, USA.

出版信息

Nicotine Tob Res. 2007 Sep;9 Suppl 3:S459-74. doi: 10.1080/14622200701587045.

Abstract

Genetic variations in the enzymes involved in alcohol and nicotine metabolism can profoundly affect the rates of metabolism of these drugs, which in turn can influence drug-taking behaviors. The frequency of these genetic variants differs substantially among ethnic groups, resulting in differing genetic influences, or degrees of risk, among different populations. For many of these enzymatic pathways, the genetic variations that affect the rates of metabolism are very different in Asians and Caucasians and may contribute to population differences in alcohol- and tobacco-related behaviors and diseases. Understanding how variations in alcohol- and nicotine-metabolizing enzymes alter these drug responses and behaviors, with special focus on genetic variations, is the subject of this review. Each section describes genetic variations in a particular enzymatic pathway and reviews what is known about population variation and the resulting impact on alcohol- and/or nicotine-related disorders. Each section concludes with some thoughts on future research priorities. Sections 1 and 2 review the primary alcohol- and acetaldehyde-metabolizing enzymes and provide a working model for how the genetic variations in these enzymes may affect alcohol consumption and related disorders. Section 1 focuses on the alcohol and acetaldehyde dehydrogenases, while section 2 focuses on CYP2E1 and its possible role in alcohol and tobacco dependence. Sections 3 and 4 describe enzymes involved in nicotine metabolism, with section 3 focusing on the major nicotine-to-cotinine metabolizing enzyme, CYP2A6, and how genetically differing rates of metabolic inactivation of nicotine alter smoking. Section 4 describes data on the many additional enzymes involved in the metabolism of nicotine and its metabolites and summarizes our current understanding of the influence these enzymes may have on metabolism and addiction in this relatively new research area.

摘要

参与酒精和尼古丁代谢的酶的基因变异会深刻影响这些药物的代谢速率,进而影响药物使用行为。这些基因变异的频率在不同种族群体中差异很大,导致不同人群受到不同的遗传影响或风险程度。对于许多这些酶促途径而言,影响代谢速率的基因变异在亚洲人和高加索人中差异很大,可能导致与酒精和烟草相关的行为及疾病在人群中存在差异。了解酒精和尼古丁代谢酶的变异如何改变这些药物反应和行为,特别是关注基因变异,是本综述的主题。每个部分都描述了特定酶促途径中的基因变异,并综述了关于人群变异以及由此对酒精和/或尼古丁相关疾病产生的影响的已知信息。每个部分最后都对未来的研究重点提出了一些想法。第1和第2部分综述了主要的酒精和乙醛代谢酶,并提供了一个工作模型,说明这些酶的基因变异可能如何影响酒精消费及相关疾病。第1部分重点关注酒精脱氢酶和乙醛脱氢酶,而第2部分重点关注CYP2E1及其在酒精和烟草依赖中的可能作用。第3和第4部分描述了参与尼古丁代谢的酶,第3部分重点关注主要的尼古丁转化为可替宁的代谢酶CYP2A6,以及尼古丁代谢失活的基因差异速率如何改变吸烟行为。第4部分描述了关于参与尼古丁及其代谢物代谢的许多其他酶的数据,并总结了我们目前对这些酶在这个相对较新的研究领域中可能对代谢和成瘾产生的影响的理解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验